文献速递角膜与眼表疾病

利用猪角膜酶解抵抗模型研究核黄素浓度对角膜交联效果的影响

An Investigation of the Effects of Riboflavin Concentration on the Efficacy of Corneal Cross-Linking Using an Enzymatic Resistance Model in Porcine Corneas.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2018-01-01

研究将96只猪眼分为五组,分别用0.05%、0.1%、0.2%、0.3%核黄素联合紫外线A(9 mW/cm²,10分钟)进行角膜交联,并以胃蛋白酶消化模型评估酶解抵抗。结果显示,随核黄素浓度升高,残留未消化组织干重增加(P < 0.001),提示存在一致的剂量-反应曲线,较高浓度核黄素可获得更强的交联效果。

要点

  • 交联处理后的角膜消化时间长于未处理角膜(P < 0.001)。
  • 不同核黄素浓度组间消化时间无显著差异(P = 0.3)。
  • 10天时,核黄素浓度每增加一档,残留未消化组织干重增加(P < 0.001)。

核心结论

  • 存在一致的剂量-反应曲线,较高浓度核黄素可获得更强的角膜交联效果,提示调整核黄素剂量以及紫外线A方案可用于优化角膜交联。

研究设计与样本

  • 研究使用96只猪眼,分两次治疗运行,共设五个组:组1未处理,组2至组5分别接受0.05%、0.1%、0.2%、0.3%核黄素处理。
  • 处理眼接受紫外线A照射,功率9 mW/cm²,时间10分钟;取8毫米角膜圆片浸入胃蛋白酶消化液。
  • 第一次运行每日测量圆片直径,10天后记录每组5个样本的干重;第二次运行在10天和20天记录每组5个样本的干重。

主要发现

  • 交联处理角膜的消化时间长于未处理角膜(P < 0.001)。
  • 较高核黄素浓度组消化时间一般更长,但组间无显著差异(P = 0.3)。
  • 第一次运行10天时,核黄素浓度每增加一档,残留未消化组织干重增加(P < 0.001)。
  • 第二次运行10天时,核黄素浓度每增加一档,残留组织干重增加(P < 0.001)。
  • 第二次运行20天时,0.05%核黄素组干重低于0.3%组(P < 0.001),也低于0.2%和0.1%组(P < 0.05),其余组间无差异。

临床怎么用

  • 原文结论提示,调整核黄素剂量以及紫外线A方案可用于优化角膜交联。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To investigate riboflavin concentration on enzymatic resistance following corneal cross-linking (CXL). METHODS: Ninety-six porcine eyes were divided into five groups in two treatment runs. Group 1 remained untreated. Group 2 received riboflavin 0.05%, group 3 riboflavin 0.1%, group 4 riboflavin 0.2%, and group 5 riboflavin 0.3%. Treated eyes underwent CXL with ultraviolet A at 9 mW/cm2 for 10 minutes. Eight-millimeter discs from each cornea were submerged in pepsin digest solution. In the first run, disc diameters were measured daily. After 10 days, dry weights were recorded from five samples in each group. In the second run, dry weights were recorded in five samples in each group at 10 and 20 days. RESULTS: CXL-treated corneas took longer to digest than untreated (P < 0.001). Although eyes treated with higher riboflavin concentrations generally took longer to digest, there were no significant differences between groups (P = 0.3). Dry weights at 10 days demonstrated, with each increase in concentration, an increase in weight of residual undigested tissue (P < 0.001). In the second run, with each increase in riboflavin concentration there was an increase in weight of residual tissue (P < 0.001) at 10 days. At 20 days, the dry weight was lower with 0.05% riboflavin compared to 0.3% (P < 0.001) and 0.2% and 0.1% solutions (P < 0.05), with no other difference between groups. CONCLUSIONS: There is a consistent dose-response curve with higher concentrations of riboflavin achieving greater CXL efficacy, suggesting that manipulation of riboflavin dosage as well as the UVA protocol can be used to optimize CXL.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. O'Brart NAL, O'Brart DPS, Aldahlawi NH, et al. An Investigation of the Effects of Riboflavin Concentration on the Efficacy of Corneal Cross-Linking Using an Enzymatic Resistance Model in Porcine Corneas. Invest Ophthalmol Vis Sci. 2018. PMID: 29490342. doi:10.1167/iovs.17-22994

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。